Cellular compartments of human immunodeficiency virus type 1 replication in vivo: Determination by presence of virion-associated host proteins and impact of opportunistic infection

Journal of Virology

Volumn 74, Issue 1, 2000, Pages 139-145

  Lawn, Stephen D ^a,b   Roberts, Beverly D ^a   Griffin, George E ^b   Folks, Thomas M ^a   Butera, Salvatore T ^a,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; HOST PARASITE INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MACROPHAGE; NONHUMAN; OPPORTUNISTIC INFECTION; PHENOTYPE; PRIORITY JOURNAL; VIRION; VIRUS ENVELOPE; VIRUS EXPRESSION; VIRUS REPLICATION;

EID: 0033989735     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.1.139-145.2000     Document Type: Article

References (33)

1. Arthur, L. O., J. W. Bess, Jr., R. C. Sowder, R. E. Benveniste, D. L. Mann, J. C. Chermann, and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implication for pathogenesis and vaccines. Science 258:1935-1938.
2. Bastiani, L., S. Laal, M. Kim, and S. Zolla-Pazner. 1997. Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions. J. Virol. 71:3444-3450.
3. Bourinbaiar, A. S. 1994. The ratio of defective HIV-1 particles to replication-competent infectious virions. Acta Virol. 38:59-61.
4. Cantin, R., J.-F. Fortin, G. Lamontagne, and M. Tremblay. 1997 The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. Blood 90:1091-1100.
5. Dierich, M. P., I. Frank, A. Stoiber, M. Clivio, M. Spruth, and H. W. Katinger. 1996. The envelope of HIV. Immunol. Lett. 54:205-206.
6. Fortin, J. F., R. Cantin, G. Lamontagne, and M. Tremblay. 1997. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71: 3588-3596.
7. Frank, I., H. Stoiber, S. Godar, H. Stockinger, F. Steindl, H. W. Katinger, and M. P. Dierich. 1996. Acquisition of host cell-surface-derived molecules by HIV-1. AIDS 10:1611-1620.
8. Frank, I., L. Kacani, H. Stoiber, H. Stüssel, M. Spruth, F. Steindl, N. Romani, and M. P. Dierich. 1999. Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious. J. Virol. 73:3449-3454.
9. Goletti, D., D. Weissman, R. W. Jackson, N. M. H. Graham, D. Vlahov, R. S. Klein, S. S. Munsiff, L. Ortona, R. Cauda, and A. S. Fauci. 1996. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J. Immunol. 157:1271-1278.
10. Guo, M. M. L., and J. E. K. Hildreth. 1995. HIV acquires functional adhesion receptors from host cells. AIDS Res. Hum. Retroviruses 11:1007-1013.
11. Hofmann, B., P. Nishanian, J. L. Fahey, I. Esmail, A. L. Jackson, R. Detels, and W. Cumberland. 1991. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change. Clin. Immunol. Immunopathol. 61:212-224.
12. Hoheisel, G., L. Zheng, H. Teschler, I. Striz, and U. Costabel. 1995. Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. Chest 108:1614-1616.
13. Huh, H. Y., S. F. Pearce, L. M. Yesner, J. L. Schindler, and R. L. Silverstein. 1996. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 87:2020-2028.
14. Kahne, T., H. Kroning, U. Thiel, A. J. Ulmer, H. D. Flad, and S. Ansorge. 1996. Alterations in structure and cellular localization of DPIV/CD26 during T cell activation. Cell. Immunol. 170:63-70.
15. Lien, E., P. Aukrust, A. Sundan, F. Muller, S. S. Froland, and T. Espevik. 1998. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 infection: correlation to disease progression and clinical events. Blood 92:2084-2092.
16. Montefiori, D. C., R. J. Cornell, J. T. Zhou, V. M. Hirsch, and P. R. Johnson. 1994. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 205:82-92.
17. Orenstein, J. M., C. Fox, and S. M. Wahl, 1997. Macrophages as a source of HIV during opportunistic infections. Science 276:1857-1861.
18. Orentas, R. J., and J. E. Hildreth. 1993, Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res. Hum. Retroviruses 9:1157-1165.
19. Perelson, A. S., A. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
20. Pugin, J., I. D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-516.
21. Roberts, B. D., and S. T. Butera. 1999. Host protein incorporation is conserved among diverse HIV-1 subtypes. AIDS 13:425-427.
22. Rossio, J. L., J. Bess, L. E. Henderson, P. Cresswell, and L. O. Arthur. 1995. HLA class II on HIV particles is functional in superantigen presentation to human T-cells: implications for HIV pathogenesis. AIDS Res. Hum. Retroviruses 11:1433-1439.
23. Saarloos, M.-N., B. L. Sullivan, M. A. Czerniewski, K. D. Parameswar, and G. T. Spear. 1997. Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1. J. Virol. 71:1640-1643.
24. Saifuddin, M., C. J. Parker, M. E. Peeples, M. K. Gorny, S. Zolla-Pazner, M. Ghassemi, I. A. Rooney, J. P. Aikinson, and G. T. Spear. 1995. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J. Exp. Med. 182:501-509.
25. Saifuddin, M., T. Hedayati, J. P. Atkinson, M. H. Holguin, C. T. Parker, and G. T. Spear. 1997. Human immunodeficiency virus type 1 incorporates both glycosylphosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J. Gen. Virol. 78:1907-1911.
26. Scheibenbogen, C., U. Keilholz, M. Richter, K. Andreesen, and W. Huntstein. 1992. The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75). Res. Immunol. 143:33-37.
27. Stemenkovic, I., A. Aruffo, M. Amiot, and B. Seed. 1989. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56:1057-1062.
28. Sullivan, B. L., E. J. Knopoff, M. Saifuddin, D. M. Takefman, M. N. Saarloos, B. E. Sha, and G. T. Spear. 1916. Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. J. Immunol. 157:1791-1798.
29. Tandon, N. N., U. Kralisz, and G. A. Jamieson. 1989. Identification of glycoprotein IV (CD36) as a primary receptor of platelet-collagen adhesion. J. Biol. Chem. 264:7576-7583.
30. Tremblay, M. J., J.-F. Fortin, and R. Cantin. 1993. The acquisition of host-encoded proteins by nascent HIV-1. Immunol. Today 19:346-351.
31. Wahl, S. M., T. Green-Wild, G. Peng, H. Hale-Donze, and J. M. Orenstein. 1999. Coinfection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages. J. Infect. Dis. 179:S457-S460.
32. Wiley, R. L., D. H. Smith, L. A. Lasky, T. S. Theodore, P. L. Earl, B. Moss, D. J. Capon, and M. A. Martin. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62:139-147.
33. Yu, W., E. Soprana, G. Cosetino, M. Volta, H. S. Lichenstein, G. Viale, and D. Vercelli. 1998. Soluble CD14 confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay. J. Immunol. 161:4244-4251.